Abstract
Primary Central Nervous System Lymphoma (PCNSL) is defined as lymphoma confined to the brain, eye, spinal cord, or leptomeninges without evidence of prior or concurrent lymphoma outside of the nervous system. Other types of lymphoma that involve the nervous system include lymphoma of peripheral nerves and nerve roots, lymphomatoid granulomatosis, and intravascular lymphoma; these lymphomas, as well as lymphoma of the dura mater are reviewed in the sections that follow.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
van der Valk P (1996) Central nervous system lymphomas. Curr Diagn Pathol 3:45–52
Iwamoto FM, DeAngelis LM (2006) An update on primary central nervous system lymphoma. Hematol Oncol Clin North Am 20:1267–1285
Rubenstein J, Ferreri AJ, Pittaluga S (2008) Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment. Leuk Lymphoma 49(Suppl 1):43–51
Cady FM, O’Neill BP, Law ME et al (2008) Del(6)(q22) and BCL6 rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course. J Clin Oncol 26:4814–4819
Nuckols J, Liu K, Burchette J et al (1999) Primary central nervous system lymphomas: a 30-year exprerience at a single institution. Mod Pathol 12:1167–1173
Camilleri-Broet S, Martin A, Moreau A et al (1998) Primary central nervous system lymphomas in 72 immunocompetent patients: pathologic findings and clinical correlations. Am J Clin Pathol 110:607–612
Eby N, Grufferman S, Flannelly C et al (1988) Increasing incidence of primary brain lymphoma in the US. Cancer 62:2461–2465
McAllister LD, Doolittle ND, Guastadisegni PE et al (2000) Congnitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma. Neurosurgery 46:51–61
Sekita T, Tamaru J, Kaito K et al (2001) Primary central nervous system lymphomas express Vh genes with intermediate to high somatic mutations. Leuk Lymphoma 41:377–385
Eichler AF, Batchelor TT (2006) Primary central nervous system lymphoma: presentation, diagnosis and staging. Neurosurg Focus 21:E15
Fischer L, Martus P, Weller M et al (2008) Meningeal dissemination in primary CNS lymphoma: prospective evaluation of 282 patients. Neurology 71:1102–1108
Miller D, Hochberg F, Harris N et al (1994) Pathology with clinical correlations of primary central nervous system non-Hodgkin’s lymphoma. The Massachusetts General Hospital experience 1958–1989. Cancer 74:1383–1397
Lin CH, Kuo KT, Chuang SS et al (2006) Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin. Clin Cancer Res 12:1152–1156
Larocca L, Capello D, Rinelli A et al (1998) The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center related B cells. Blood 92:1011–1019
Camilleri-Broet S, Davi F, Feuillard J et al (1997) AIDS-related primary brain lymphomas: histopathologic and immunohistochemical study of 51 cases. The French Study Group for HIV-Associated Tumors. Hum Pathol 28:367–374
Kirk O, Pedersen C, Cozz-Lepri A et al (2001) Non-Hodgkin’s lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood 98:3406–3412
Herrlinger U, Schabet M, Brugger W et al (2001) Primary central nervous system lymphoma 1991–1997: outcome and late adverse effects after combined modality treatment. Cancer 91:130–135
DeAngelis L (1991) Primary central nervous system lymphoma as a secondary malignancy. Cancer 67:1431–1435
DeAngelis L (1999) Primary central nervous system lymphoma. J Neurol Neurosurg Psychiatry 66:699–701
Finn WG, Peterson LC, James C, Goolsby CL (1998) Enhanced detection of malignant lymphoma in cerebrospinal fluid by multiparameter flow cytometry. Am J Clin Pathol 110:341–346
Antinori A, Larocca L, Fassone L et al (1999) HHV-8/KSHV is not associated with AIDS-related primary central nervous system lymphoma. Brain Pathol 9:199–208
DeLuca A, Antinori A, Cingolani A et al (1995) Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma. Brit J Haematol 90:844–849
Corcoran C, Rebe K, van der Plas H et al (2008) The predictive value of cerebrospinal fluid Epstein–Barr viral load as a marker of primary central nervous system lymphoma in HIV-infected persons. J Clin Virol 42:433–436
Kluin P, Deckert M, Ferry J (2008) Primary diffuse large B-cell lymphoma of the CNS. In: Swerdlow S, Campo E, Harris N et al(eds) WHO classification tumours of haematopoietic and lymphoid tissues, 4th edn. IARC Press, Lyon, 240–241
Rivero M, Kuppermann B, Wiley C et al (1999) Acquired immunodeficiency syndrome-related intraocular B-cell lymphoma. Arch Ophthalmol 117:616–622
Porter AB, Giannini C, Kaufmann T et al (2008) Primary central nervous system lymphoma can be histologically diagnosed after previous corticosteroid use: a pilot study to determine whether corticosteroids prevent the diagnosis of primary central nervous system lymphoma. Ann Neurol 63:662–667
Castellano-Sanchez AA, Li S, Qian J et al (2004) Primary central nervous system posttransplant lymphoproliferative disorders. Am J Clin Pathol 121:246–253
Commins DL (2006) Pathology of primary central nervous system lymphoma. Neurosurg Focus 21:E2
Rollins KE, Kleinschmidt-DeMasters BK et al (2005) Lymphomatosis cerebri as a cause of white matter dementia. Hum Pathol 36:282–290
Grove A, Vyberg M (1993) Primary leptomeningeal T-cell lymphoma: a case and a review of primary T-cell lymphoma of the central nervous system. Clin Neuropathol 12:7–12
Alderson L, Fetell MR, Sisti M et al (1996) Sentinel lesions of primary CNS lymphoma. J Neurol Neurosurg Psychiatry 60:102–105
Stein H, Warnke R, Chan W et al (2008) Diffuse large B-cell lymphoma, not otherwise specified. In: Swerdlow S, Campo E, Harris N et al(eds) WHO classification tumours of haematopoietic and lymphoid tissues, 4th edn. IARC Press, Lyon, 233–237
Capello D, Martini M, Gloghini A et al (2008) Molecular analysis of immunoglobulin variable genes in human immunodeficiency virus-related non-Hodgkin’s lymphoma reveals implications for disease pathogenesis and histogenesis. Haematologica 93:1178–1185
Herrlinger U, Schabet M, Clemens M et al (1998) Clinical presentation and therapeutic outcome in 26 patients with primary CNS lymphoma. Acta Neurol Scand 97:257–264
Thompsett A, Ellison D, Stevenson F, Zhu D (1999) VH gene sequences from primary central nervous system lymphomas indicate derivation from highly mutated germinal center B cells with ongoing mutational activity. Blood 94:1738–1746
Swerdlow S, Webber S, Chadburn A, Ferry J (2008) Post-transplant lymphoproliferative disorders. In: Swerdlow S, Campo E, Harris N et al(eds) WHO classification tumours of haematopoietic and lymphoid tissues, 4th edn. IARC Press, Lyon, 343–349
Cavaliere R, Petroni G, Lopes MB, Schiff D (2010) Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group report. Cancer 116(4):863–870
Bigner SH (1992) Cerebrospinal fluid (CSF) cytology: current status and diagnostic applications. J Neuropathol Exp Neurol 51:235–245
Haldorsen IS, Krakenes J, Goplen AK et al (2008) AIDS-related primary central nervous system lymphoma: a Norwegian national survey 1989–2003. BMC Cancer 8:225
Montesinos-Rongen M, Schmitz R, Courts C et al (2005) Absence of immunoglobulin class switch in primary lymphomas of the central nervous system. Am J Pathol 166:1773–1779
Levy O, Deangelis LM, Filippa DA et al (2008) Bcl-6 predicts improved prognosis in primary central nervous system lymphoma. Cancer 112:151–156
Camilleri-Broet S, Criniere E, Broet P et al (2006) A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases. Blood 107:190–196
Braaten KM, Betensky RA, de Leval L et al (2003) BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma. Clin Cancer Res 9:1063–1069
Sugita Y, Tokunaga O, Nakashima A, Shigemori M (2004) SHP-1 expression in primary central nervous system B-cell lymphomas in immunocompetent patients reflects maturation stage of normal B cell counterparts. Pathol Int 54:659–666
Hans CP, Weisenburger DD, Greiner TC et al (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103:275–282
Bhagavathi S, Wilson JD (2008) Primary central nervous system lymphoma. Arch Pathol Lab Med 132:1830–1834
Riemersma SA, Jordanova ES, Schop RF et al (2000) Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites. Blood 96:3569–3577
Montesinos-Rongen M, Van Roost D, Schaller C et al (2004) Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation. Blood 103:1869–1875
Schwindt H, Akasaka T, Zuhlke-Jenisch R et al (2006) Chromosomal translocations fusing the BCL6 gene to different partner loci are recurrent in primary central nervous system lymphoma and may be associated with aberrant somatic hypermutation or defective class switch recombination. J Neuropathol Exp Neurol 65:776–782
McCann KJ, Ashton-Key M, Smith K et al (2009) Primary central nervous system lymphoma: tumor-related clones exist in the blood and bone marrow with evidence for separate development. Blood 113:4677–4680
Montesinos-Rongen M, Siebert R, Deckert M (2009) Primary lymphoma of the central nervous system: just DLBCL or not? Blood 113:7–10
Cassoux N, Merle-Beral H, Leblond V et al (2000) Ocular and central nervous system lymphoma: clinical features and diagnosis. Ocul Immunol Inflamm 8:243–250
Freeman L, Schachat A, Knox D (1987) Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. Ophthalmology 94:1631–1639
Peterson K, Gordon K, Heinemann M-H, DeAngelis L (1993) The clinical spectrum of ocular lymphoma. Cancer 72:843–849
Whitcup S, de Smet M, Rubin B et al (1993) Intraocular lymphoma. Clinical and histopathologic diagnosis. Ophthalmology 100:1399–1406
Ridley M, McDonald H, Sternberg P Jr. et al (1992) Retinal manifestations of ocular lymphoma (reticulum cell sarcoma). Ophthalmology 99:1153–1161
Hochberg F, Miller D (1988) Primary central nervous system lymphoma (Review). J Neurosurg 68:835–853
Stephenson P, Duffey R, Ferguson J Jr. (1989) Intraocular histiocytic lymphoma: a pediatric case presentation. J Pediatr Ophthalmol Strabismus 26:296–298
Buggage R, Chan C, Nussenblatt R (2001) Ocular manifestations of central nervous system. Curr Opin Oncol 13:137–142
Grimm SA, McCannel CA, Omuro AM et al (2008) Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group report. Neurology 71:1355–1360
Maier W, Laubert A, Weinel P (1994) Acute bilateral blindness in childhood caused by rhabdomyosarcoma and malignant lymphoma. J Laryngol Otol 108:873–877
Baehring JM, Androudi S, Longtine JJ et al (2005) Analysis of clonal immunoglobulin heavy chain rearrangements in ocular lymphoma. Cancer 104:591–597
Clark W, Scott I, Murray T et al (1998) Primary intraocular posttransplantation lymphoproliferative disorder. Arch Ophthalmol 116:1667–1669
Karma A, von Willebrand EO, Tommila PV et al (2007) Primary intraocular lymphoma: improving the diagnostic procedure. Ophthalmology 114:1372–1377
Merle-Beral H, Davi F, Cassoux N et al (2004) Biological diagnosis of primary intraocular lymphoma. Br J Haematol 124:469–473
Frenkel S, Hendler K, Siegal T et al (2008) Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience. Br J Ophthalmol 92:383–388
Maiuri F (1990) Visual involvement in primary non-Hodgkin’s lymphomas. Clin Neurol Neurosurg 92:119–124
Dean JM, Novak MA, Chan CC, Green WR (1996) Tumor detachments of the retinal pigment epithelium in ocular/central nervous system lymphoma. Retina 16:47–56
Chan CC (2003) Molecular pathology of primary intraocular lymphoma. Trans Am Ophthalmol Soc 101:275–292
Ziemianski M, Godfrey W, Lee K, Sabates F (1980) Lymphoma of the vitreous associated with renal transplantation and immunosuppressive therapy. Ophthalmology 87:596–601
Schanzer MC, Font RL, O’Malley RE (1991) Primary ocular malignant lymphoma associated with the acquired immune deficiency syndrome. Ophthalmology 98:88–91
Char D, Ljung B-M, Miller T, Phillips T (1988) Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management. Ophthalmology 95:625–630
Buettner H, Bolling J (1993) Intravitreal large-cell lymphoma. Mayo Clin Proc 68:1011–1015
Brown S, Jampol L, Cantrill H (1994) Intraocular lymphoma presenting as retinal vasculitis. Surv Ophthalmol 39:133–140
Kohno T, Uchida H, Inomata H et al (1993) Ocular manifestations of adult T-cell leukemia/lymphoma. A clinicopathologic study. Ophthalmology 100:1794–1799
Coupland SE, Hummel M, Muller HH, Stein H (2005) Molecular analysis of immunoglobulin genes in primary intraocular lymphoma. Invest Ophthalmol Vis Sci 46:3507–3514
Gunduz K, Pulido JS, McCannel CA, O’Neill BP (2006) Ocular manifestations and treatment of central nervous system lymphomas. Neurosurg Focus 21:E9
Jahnke K, Korfel A, O’Neill BP et al (2006) International study on low-grade primary central nervous system lymphoma. Ann Neurol 59:755–762
Jahnke K, Thiel E, Schilling A et al (2005) Low-grade primary central nervous system lymphoma in immunocompetent patients. Br J Haematol 128:616–624
George DH, Scheithauer BW, Aker FV et al (2003) Primary anaplastic large cell lymphoma of the central nervous system: prognostic effect of ALK-1 expression. Am J Surg Pathol 27:487–493
Merlin E, Chabrier S, Verkarre V et al (2008) Primary leptomeningeal ALK+ lymphoma in a 13-year-old child. J Pediatr Hematol Oncol 30:963–967
Rupani A, Modi C, Desai S, Rege J (2005) Primary anaplastic large cell lymphoma of central nervous system – a case report. J Postgrad Med 51:326–327
Paulus W (1999) Classification, pathogenesis and molecular pathology of primary CNS lymphomas. J Neurooncol 43:203–208
Shuangshoti S, Assanasen T, Lerdlum S et al (2008) Primary central nervous system plasmablastic lymphoma in AIDS. Neuropathol Appl Neurobiol 34:245–247
Stein H, Harris N, Campo E (2008) Plasmablastic lymphoma. In: Swerdlow S, Campo E, Harris N et al(eds) WHO classification tumours of haematopoietic and lymphoid tissues, 4th edn. IARC Press, Lyon, 256–257
Park I, Huh J, Kim JH et al (2008) Primary central nervous system marginal zone B-cell lymphoma of the basal ganglia mimicking low-grade glioma: a case report and review of the literature. Clin Lymphoma Myeloma 8:305–308
Omori N, Narai H, Tanaka T et al (2008) Epstein–Barr virus-associated T/NK cell-type central nervous system lymphoma which manifested as a post-transplantation lymphoproliferative disorder in a renal transplant recipient. J Neurooncol 87:189–191
Kaluza V, Rao DS, Said JW, de Vos S (2006) Primary extranodal nasal-type natural killer/T-cell lymphoma of the brain: a case report. Hum Pathol 37:769–772
Klein R, Mullges W, Bendszus M et al (1999) Primary intracerebral Hodgkin’s disease: report of a case with Epstein–Barr virus association and review of the literature. Am J Surg Pathol 23:477–481
Gerstner ER, Abrey LE, Schiff D et al (2008) CNS Hodgkin lymphoma. Blood 112:1658–1661
Nakamura S, Ponzoni M, Campo E (2008) Intravascular large B-cell lymphoma. In: Swerdlow S, Campo E, Harris N et al(eds) WHO classification tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, 252–253
Pfleger L, Zur TJ (1959) Kenntnis der systemisierten Endotheliomatose der cutanen Blutgefässe (Reticuloendotheliose?). Hautarzt 10:359–363
Ferreri AJ, Campo E, Seymour JF et al (2004) Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’. Br J Haematol 127:173–183
Roglin J, Boer A (2007) Skin manifestations of intravascular lymphoma mimic inflammatory diseases of the skin. Br J Dermatol 157:16–25
Ferreri AJ, Dognini GP, Campo E et al (2007) Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions. Haematologica 92:486–492
Murase T, Nakamura S, Kawauchi K et al (2000) An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome. Br J Haematol 111:826–834
DiGiuseppe JA, Nelson WG, Seifter EJ et al (1994) Intravascular lymphomatosis: a clinicopathologic study of 10 cases and assessment of response to chemotherapy. J Clin Oncol 12:2573–2579
Ferry JA, Harris NL, Picker LJ et al (1988) Intravascular lymphomatosis (malignant angioendotheliomatosis). A B-cell neoplasm expressing surface homing receptors. Mod Pathol 1:444–452
Zuckerman D, Seliem R, Hochberg E (2006) Intravascular lymphoma: the oncologist’s ‘great imitator’. Oncologist 11:496–502
Ponzoni M, Arrigoni G, Gould VE et al (2000) Lack of CD 29 (beta1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. Hum Pathol 31:220–226
Kutzner H, Jaffe E (2006) Intravascular large B-cell lymphoma. In: LeBoit P, Burg G, Weedon D, Sarasin A, (eds) Pathology and genetics: skin tumours. IARC Press, Lyon, 200–201
Gatter K, Warnke R (2001) Intravascular large B-cell lymphoma. In: Jaffe E, Harris N, Stein H, Vardiman J, (eds) Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, 177–178
Pittaluga S, Wilson W, Jaffe E (2008) Lymphomatoid granulomatosis. In: Swerdlow S, Campo E, Harris N et al(eds) WHO classification tumours of haematopoietic and lymphoid tissues, 4th edn. IARC Press, Lyon, 247–249
Choi JS, Nam DH, Ko YH et al (2003) Primary central nervous system lymphoma in Korea: comparison of B- and T-cell lymphomas. Am J Surg Pathol 27:919–928
Villegas E, Villa S, Lopez-Guillermo A et al (1997) Primary central nervous system lymphoma of T-cell origin: description of two cases and review of the literature. J Neurooncol 34:157–161
Shenkier TN, Voss N, Chhanabhai M et al (2005) The treatment of primary central nervous system lymphoma in 122 immunocompetent patients: a population-based study of successively treated cohorts from the British Colombia Cancer Agency. Cancer 103:1008–1017
Misdraji J, Ino Y, Louis D et al (2000) Primary lymphoma of peripheral nerve. Am J Surg Pathol 24:1257–1265
Quinones-Hinojosa A, Friedlander R, Boyer P et al (2000) Solitary sciatic nerve lymphoma as an initial manifestation of diffuse neurolymphomatosis. J Neurosurg 92:165–169
Abad S, Zagdanski A, Sabine B et al (1999) Neurolymphomatosis in Waldenstrom’s macroglobulinaemia. Br J Haematol 106:100–103
Diaz-Arrastia R, Younger D, Hair L et al (1992) Neurolymphomatosis: a clinicopathologic syndrome re-emerges. Neurology 42:1136–1141
Baehring JM, Damek D, Martin EC et al (2003) Neurolymphomatosis. Neurooncol 5:104–115
Descamps MJ, Barrett L, Groves M et al (2006) Primary sciatic nerve lymphoma: a case report and review of the literature. J Neurol Neurosurg Psychiatry 77:1087–1089
Ghobrial IM, Buadi F, Spinner RJ et al (2004) High-dose intravenous methotrexate followed by autologous stem cell transplantation as a potentially effective therapy for neurolymphomatosis. Cancer 100:2403–2407
Yamada SM, Ikawa N, Toyonaga S et al (2006) Primary malignant B-cell-type dural lymphoma: case report. Surg Neurol 66:539–543; discussion 43
Iwamoto FM, DeAngelis LM, Abrey LE (2006) Primary dural lymphomas: a clinicopathologic study of treatment and outcome in eight patients. Neurology 66:1763–1765
Kumar S, Kumar D, Kaldjian E et al (1997) Primary low-grade B-cell lymphoma of the dura: a mucosa associated lymphoid tissue-type lymphoma. Am J Surg Pathol 21:81–87
Lehman N, Horoupian D, Warnke R et al (2002) Dural marginal zone lymphoma with massive amyloid deposition: rare low-grade primary central nervous system B-cell lymphoma. J Neurosurg 96:368–372
Altundag M, Ozisik Y, Yalcin S et al (2000) Primary low grade B-cell lymphoma of the dura in an immunocompetent patient. J Exp Clin Cancer Res 19:249–251
Freudenstein D, Bornemann A, Ernemann U et al (2000) Intracranial malignant B-cell lymphoma of the dura. Clin Neuropathol 19:34–37
Kambham N, Chang Y, Matsushima A (1998) Primary low-grade B-cell lymphoma of mucosa-associated lymphoma tissue (MALT) arising in dura. Clin Neuropathol 17:311–317
Miranda R, Glantz L, Myint M et al (1996) Stage IE non-Hodgkin’s lymphoma involving the dura: A clinicopathologic study of five cases. Arch Pathol Lab Med 120:254–260
Bhagavathi S, Greiner T, Kazmi S et al (2008) Extranodal marginal zone lymphoma of the dura mater with IgH/MALT1 translocation and review of the literature. J Hematopathol 1:131–137
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Ferry, J.A., Pfannl, R., Harris, N.L. (2012). Pathology of Primary Central Nervous System Lymphoma and Related Conditions. In: Batchelor, T., DeAngelis, L. (eds) Lymphoma and Leukemia of the Nervous System. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7668-0_3
Download citation
DOI: https://doi.org/10.1007/978-1-4419-7668-0_3
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-7667-3
Online ISBN: 978-1-4419-7668-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)